Larry Gold, PhD
Chairman, Founder, and CEO of SomaLogic; Founder of NeXstar and Synergen
During his career, Gold has received many citations including the University of Colorado Distinguished Lectureship Award, the National Institutes of Health Merit Award, the Career Development Award, and the Chiron Prize for Biotechnology. In addition, Gold has been a member of the American Academy of Arts and Sciences since 1993 and the National Academy of Sciences since 1995.
SomaLogic is developing reagents that focus on proteins to detect the early onset of diseases quickly, effectively and economically. Dr. Gold received an AB in Biochemistry from Yale University and a PhD in Biochemistry from the University of Connecticut.
Gold is excited about his involvement with the Linda Crnic Institute for Down Syndrome and sees a positive future for Down syndrome research.
“I am so pleased to be part of this endeavor, with such good people,” says Gold. “Years ago I thought that interventions in the cognitive lives of people with Down syndrome was close to impossible, and today, thanks to lots of reading and listening, I believe that positive interventions are a certainty. The Linda Crnic Institute will certainly lead this effort.”